Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms.

Zhang QG, Buckling A.

Evol Appl. 2012 Sep;5(6):575-82. doi: 10.1111/j.1752-4571.2011.00236.x. Epub 2012 Jan 13.

2.

Phage therapy--constraints and possibilities.

Nilsson AS.

Ups J Med Sci. 2014 May;119(2):192-8. doi: 10.3109/03009734.2014.902878. Epub 2014 Mar 30. Review.

3.

Evolutionary Rationale for Phages as Complements of Antibiotics.

Torres-Barceló C, Hochberg ME.

Trends Microbiol. 2016 Apr;24(4):249-56. doi: 10.1016/j.tim.2015.12.011. Epub 2016 Jan 17. Review.

PMID:
26786863
4.

Bacterial evolution and the cost of antibiotic resistance.

Lenski RE.

Int Microbiol. 1998 Dec;1(4):265-70. Review.

PMID:
10943373
5.

The cost of antibiotic resistance--from the perspective of a bacterium.

Lenski RE.

Ciba Found Symp. 1997;207:131-40; discussion 141-51. Review.

PMID:
9189639
6.

Exploring the risks of phage application in the environment.

Meaden S, Koskella B.

Front Microbiol. 2013 Nov 29;4:358. doi: 10.3389/fmicb.2013.00358. eCollection 2013. Review.

7.

Antimicrobial resistance in foodborne pathogens--a cause for concern?

Walsh C, Fanning S.

Curr Drug Targets. 2008 Sep;9(9):808-15. Review.

PMID:
18781926
8.

The emergence of antibiotic resistance by mutation.

Woodford N, Ellington MJ.

Clin Microbiol Infect. 2007 Jan;13(1):5-18. Review.

9.

Antibiotic resistance and its cost: is it possible to reverse resistance?

Andersson DI, Hughes D.

Nat Rev Microbiol. 2010 Apr;8(4):260-71. doi: 10.1038/nrmicro2319. Epub 2010 Mar 8. Review.

PMID:
20208551
10.

Modified phages: novel antimicrobial agents to combat infectious diseases.

Moradpour Z, Ghasemian A.

Biotechnol Adv. 2011 Nov-Dec;29(6):732-8. doi: 10.1016/j.biotechadv.2011.06.003. Epub 2011 Jun 15. Review.

PMID:
21689739
11.

Clinical pharmacology of antimicrobial use in humans and animals.

Lathers CM.

J Clin Pharmacol. 2002 Jun;42(6):587-600. Review.

PMID:
12043947
12.

Bacteria-virus coevolution.

Buckling A, Brockhurst M.

Adv Exp Med Biol. 2012;751:347-70. doi: 10.1007/978-1-4614-3567-9_16. Review.

PMID:
22821466
13.

Limits to compensatory adaptation and the persistence of antibiotic resistance in pathogenic bacteria.

MacLean RC, Vogwill T.

Evol Med Public Health. 2014 Dec 21;2015(1):4-12. doi: 10.1093/emph/eou032. Review.

14.

Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.

Burrowes B, Harper DR, Anderson J, McConville M, Enright MC.

Expert Rev Anti Infect Ther. 2011 Sep;9(9):775-85. doi: 10.1586/eri.11.90. Review.

PMID:
21905786
15.

Antibiotic usage in animals: impact on bacterial resistance and public health.

van den Bogaard AE, Stobberingh EE.

Drugs. 1999 Oct;58(4):589-607. Review.

PMID:
10551432
16.

Bacteriophage therapy in children: facts and prospects.

Fortuna W, Miedzybrodzki R, Weber-Dabrowska B, Górski A.

Med Sci Monit. 2008 Aug;14(8):RA126-32. Review.

PMID:
18668009
17.

[The cost of antibiotic resistance: analysis and consequences].

Kempf I, Zeitouni S.

Pathol Biol (Paris). 2012 Apr;60(2):e9-14. doi: 10.1016/j.patbio.2009.10.013. Epub 2009 Nov 25. Review. French.

PMID:
19942376
18.

Population and evolutionary dynamics of phage therapy.

Levin BR, Bull JJ.

Nat Rev Microbiol. 2004 Feb;2(2):166-73. Review.

PMID:
15040264
19.

Study of therapeutic potential of the experimental pseudomonas bacteriophage preparation.

Dzuliashvili M, Gabitashvili K, Golidjashvili A, Hoyle N, Gachechiladze K.

Georgian Med News. 2007 Jun;(147):81-8. Review.

PMID:
17660609
20.

Fitness of antimicrobial-resistant Campylobacter and Salmonella.

Zhang Q, Sahin O, McDermott PF, Payot S.

Microbes Infect. 2006 Jun;8(7):1972-8. Epub 2006 Mar 31. Review.

PMID:
16714138
Items per page

Supplemental Content

Write to the Help Desk